We represented direct purchasers of the drug Zetia, who alleged that the defendants conspired to delay the launch of cheaper generic versions of ezetimibe. As members of the Executive Committee and active members of the trial team, we helped achieve a favorable settlement for our clients at the beginning of the trial.